Alerts will be sent to your verified email
Verify Email
NORRIS
|
Norris Medicines
|
Link Pharma Chem
|
Cian Healthcare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
25.68 % | 1.59 % | -17.04 % |
|
5yr average Equity Multiplier
|
-1.27 | 1.99 | 3.21 |
|
5yr Average Asset Turnover Ratio
|
0.6 | 1.33 | 0.39 |
|
5yr Avg Net Profit Margin
|
-27.67 % | -0.06 % | -17.41 % |
|
Price to Book
|
0.0 | 1.07 | 0.43 |
|
P/E
|
0.0 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
113.0 Days | 82.44 Days | 55.28 Days |
|
Inventory Days
|
182.62 Days | 64.96 Days | 219.95 Days |
|
Days Receivable
|
77.44 Days | 72.97 Days | 224.43 Days |
|
Days Payable
|
195.35 Days | 84.21 Days | 542.88 Days |
|
5yr Average Interest Coverage Ratio
|
-1.07 | 2.35 | -0.81 |
|
5yr Avg ROCE
|
-18.91 % | 5.35 % | -0.26 % |
|
5yr Avg Operating Profit Margin
|
-2.35 % | 3.76 % | 7.22 % |
|
5 yr average Debt to Equity
|
-1.84 | 0.49 | 1.21 |
|
5yr CAGR Net Profit
|
-24.21 % | n/a | n/a |
|
5yr Average Return on Assets
|
-17.47 % | 0.6 % | -3.63 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
34.0 % | 51.49 % | 27.1 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 34.48 % |
|
Change in Promoter Holding (3 Yrs)
|
-0.04 % | 0.0 | -43.79 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Norris Medicines
|
Link Pharma Chem
|
Cian Healthcare
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|